Patents by Inventor Atique U. Ahmed

Atique U. Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH MODULATION OF PURINE BIOSYNTHESIS PATHWAYS
    Publication number: 20240000819
    Abstract: Disclosed are methods and compositions for treating proliferative cell diseases and disorders such as cancers. Particularly disclosed are methods and composition for treating cancers such as glioblastoma by administering a therapeutic agent that alters the pathways used for purine biosynthesis by inhibiting the biological activity of ARL13B and/or IMPDH proteins in conjunction with additional therapeutic agents such as alkylating agents.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Inventors: Atique U. Ahmed, Jack M. Shireman, Cheol H. Park
  • Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways
    Patent number: 11786542
    Abstract: Disclosed are methods and compositions for treating proliferative cell diseases and disorders such as cancers. Particularly disclosed are methods and composition for treating cancers such as glioblastoma by administering a therapeutic agent that alters the pathways used for purine biosynthesis by inhibiting the biological activity of ARL13B and/or IMPDH proteins in conjunction with additional therapeutic agents such as alkylating agents.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: October 17, 2023
    Assignee: Northwestern University
    Inventors: Atique U. Ahmed, Jack M. Shireman, Cheol H. Park
  • METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH MODULATION OF PURINE BIOSYNTHESIS PATHWAYS
    Publication number: 20210145855
    Abstract: Disclosed are methods and compositions for treating proliferative cell diseases and disorders such as cancers. Particularly disclosed are methods and composition for treating cancers such as glioblastoma by administering a therapeutic agent that alters the pathways used for purine biosynthesis by inhibiting the biological activity of ARL13B and/or IMPDH proteins in conjunction with additional therapeutic agents such as alkylating agents.
    Type: Application
    Filed: November 13, 2020
    Publication date: May 20, 2021
    Inventors: Atique U. Ahmed, Jack M. Shireman, Cheol H. Park